Dr. Anup Katheria, MD
Claim this profileSharp Mary Birch Hospital for Women & Newborns
Studies Acute Respiratory Distress Syndrome
Studies Neonatal Respiratory Distress Syndrome
21 reported clinical trials
31 drugs studied
About Anup Katheria, MD
Education:
- Earned an MD from the University of California, San Diego School of Medicine in 2006.
Experience:
- Serves as the Medical Director of the Neonatal Research Institute at Sharp Mary Birch Hospital for Women & Newborns.
- Holds the position of Associate Professor of Pediatrics at the University of California, San Diego School of Medicine.
- Specializes in neonatology and neonatal resuscitation.
Affiliated Hospitals
Clinical Trials Anup Katheria, MD is currently running
Delayed Cord Clamping Techniques
for Newborns with Congenital Heart Disease
The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis of congenital heart disease (CHD). The main questions it aims to answer are: * Does Delayed Cord Clamping at 120 seconds (DCC-120) or Delayed Cord Clamping at 30 seconds (DCC-30) after birth lead to better health outcomes? * Does DCC-120 seconds or DCC-30 seconds after birth lead to better neuromotor outcomes at 22-26 months of infant age (postnatal)? Participants will be asked to do the following: * Participate in either DCC-120 or DCC-30 at birth (randomized assignment). * Complete General Movements Assessment (GMA) at 3-4 months of infant age (postnatal), complete questionnaires / surveys at this time. * Complete questionnaires / surveys at 9-12 months of infant age (postnatal). * Complete Hammersmith Infant Neurological Examination (HINE), Developmental Assessment of Young Children 2 Edition (DAYC-2), and questionnaires / surveys at 22-26 months of infant age (postnatal). * Permit data collection from electronic medical records for both the mother and infant study participants. Investigators will compare DCC-120 vs. DCC-30 to see which approach is more beneficial to both the mother and baby with CHD.
Recruiting1 award N/A4 criteria
Antibiotics
for Neonatal Infections
The goal of the NANO trial is to study the longstanding clinical practice of empirically administering intravenous antibiotics to extremely low birthweight (ELBW) infants in the first days of life. In this 802-subject multicenter placebo-controlled randomized clinical trial, the hypothesis to be tested is that the incidence of adverse outcomes is higher in babies receiving empiric antibiotics (EA) in the first week of life compared to babies receiving placebo. The study targets a population of ELBW infants in whom the clinical decision to use or not use EA is currently most challenging -- infants that are clinically stable that did not have a known exposure to intraamniotic infection and were not born preterm for maternal indications. The primary outcome is the composite outcome of late-onset sepsis (LOS), necrotizing enterocolitis (NEC), or death during the index hospitalization. Secondary safety outcomes will include total antibiotic days, days to full enteral feedings, and common morbidities in preterm infants that have previously been linked to EA, e.g. retinopathy of prematurity and bronchopulmonary dysplasia. Weight and length z-score, and head circumference, are standard measures to be collected weekly by clinical team per a standardized protocol.
Recruiting2 awards Phase 41 criteria
More about Anup Katheria, MD
Clinical Trial Related4 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Anup Katheria, MD has experience with
- Umbilical Cord Milking
- Early Cord Clamping
- Ampicillin
- None
- Umbilical Cord Clamping At ~120 Seconds
- Umbilical Cord Clamping At ~30 Seconds
Breakdown of trials Anup Katheria, MD has run
Acute Respiratory Distress Syndrome
Neonatal Respiratory Distress Syndrome
Premature Infants
Premature Birth
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anup Katheria, MD specialize in?
Anup Katheria, MD focuses on Acute Respiratory Distress Syndrome and Neonatal Respiratory Distress Syndrome. In particular, much of their work with Acute Respiratory Distress Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Anup Katheria, MD currently recruiting for clinical trials?
Yes, Anup Katheria, MD is currently recruiting for 4 clinical trials in San Diego California. If you're interested in participating, you should apply.
Are there any treatments that Anup Katheria, MD has studied deeply?
Yes, Anup Katheria, MD has studied treatments such as Umbilical Cord Milking, Early Cord Clamping, Ampicillin.
What is the best way to schedule an appointment with Anup Katheria, MD?
Apply for one of the trials that Anup Katheria, MD is conducting.
What is the office address of Anup Katheria, MD?
The office of Anup Katheria, MD is located at: Sharp Mary Birch Hospital for Women & Newborns, San Diego, California 92123 United States. This is the address for their practice at the Sharp Mary Birch Hospital for Women & Newborns.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.